Spots Global Cancer Trial Database for Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy
Official Title: A Multicenter, Randomized, Single-blind, Parallel Controlled Clinical Study on the Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy
Study ID: NCT04727034
Study Description
Brief Summary: Propofol is the most commonly used intravenous anesthetic for painless gastroscopy, but propofol significantly inhibits the respiratory and circulatory systems. Therefore, the incidence of intraoperative hypoxemia and hypotension is high. Remazolam tosylate is an ultra-short-acting benzodiazepine drug, which has a mild inhibitory effect on the respiratory and circulatory systems and has anterograde amnesia. These advantages make remazolam tosylate very likely to replace propofol in painless gastroscopic anesthesia.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Renji Hospital, Shanghai, Shanghai, China, China
Shanghai East Hospital, Shanghai, Shanghai, China, China
Affiliated Hospital of Jiaxing University, Jiaxing, , China
The Second Affifiliated Hospital of Jiaxing University, Jiaxing, , China
The First Affiliated Hospital of Nanchang University, Nanchang, , China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
